What Does SNDA Stand For?
SNDA stands for Supplemental New Drug Application
SNDA, or Supplemental New Drug Application, is a regulatory submission to the U.S. Food and Drug Administration (FDA) that seeks approval for changes to an already approved drug. This may include modifications such as new indications, changes in formulation, or alterations in manufacturing processes. The SNDA allows pharmaceutical companies to expand or update the uses of their products based on new clinical data or changes in therapeutic guidelines, ensuring ongoing compliance with safety and efficacy standards.
Added on 14th April 2008 | Last edited on 16th June 2025 | Edit Acronym